LOS ANGELES CAPITAL MANAGEMENT LLC - ARRAY BIOPHARMA INC ownership

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$4,320,000
+49.1%
93,250
-21.5%
0.02%
+43.8%
Q1 2019$2,898,000
+369.7%
118,855
+174.3%
0.02%
+300.0%
Q4 2018$617,000
-44.6%
43,330
-40.8%
0.00%
-33.3%
Q3 2018$1,113,000
-56.3%
73,220
-51.8%
0.01%
-57.1%
Q2 2018$2,547,000
+33.7%
151,765
+30.0%
0.01%
+27.3%
Q1 2018$1,905,000
+42.4%
116,725
+7.3%
0.01%
+37.5%
Q3 2017$1,338,000
+1116.4%
108,815
+729.7%
0.01%
+700.0%
Q2 2017$110,000
-93.7%
13,115
-94.9%
0.00%
-93.3%
Q3 2016$1,748,000
+88.6%
258,935
-0.6%
0.02%
+87.5%
Q2 2016$927,000
+15.0%
260,460
-4.7%
0.01%
+14.3%
Q1 2016$806,000
-32.0%
273,320
-2.7%
0.01%
-36.4%
Q4 2015$1,185,000
+1545.8%
280,820
+1684.1%
0.01%
+1000.0%
Q3 2015$72,00015,7400.00%
Other shareholders

There were no reported owners of ARRAY BIOPHARMA INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of ARRAY BIOPHARMA INC shareholders